Jennifer Doudna, a Nobel Prize winner and co-inventor of CRISPR-Cas9, voiced a cautious view on the outsized expectations around AI in medicine and drug discovery on Bloomberg Originals' program "The Circuit with Emily Chang." According to a Bloomberg article and the official YouTube video released on June 24, 2026, Doudna responded to the question of whether AI will cure cancer by saying that scientific breakthroughs still require human ingenuity and a great deal of hard work, adding that in her own lab she has not seen chatbot-style AI independently generate innovation.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.